A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists discovered that serious viral infections can alter immune cells in the ...

The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Study to evaluate clinical performance of CyPath® Lung for the early detection of lung cancer in high-risk patientsMurtha Cancer Center Research Program at Uniformed Services University of the Health ...

Five-year survival rates are among the lowest of all cancers, at about 25%. But when caught early enough – through annual CT ...

SAN ANTONIO, March 13, 2026--bioAffinity Technologies reports financial results for FY 2025, including record revenue and unit sales for the CyPath Lung test for lung cancer.

Also, Medtech Global has integrated a clinical documentation AI into its popular patient management system in New Zealand.

A UVA Health study finds severe viral infections can prime the lungs for cancer, but vaccination appears to reduce that risk.

Oncologists currently have limited tools to predict which lung cancer patients will benefit from immunotherapy. The publication of a multi-institutional study in the Journal for ImmunoTherapy of ...

A new study finds Black Medicare beneficiaries with early-stage non–small cell lung cancer (NSCLC) continues to receive curative treatment at lower rates than White patients, highlighting ongoing ...

Severe COVID or flu may quietly raise lung cancer risk—but vaccines appear to stop the damage before it starts.

Researchers at the University of Gothenburg have identified a protein linked to an increased risk of metastasis and recurrence in lung cancer. The findings are presented in a study published in the ...